Key Financial Performance (Q2 FY27)
Revenue Performance:
- Quarterly revenue: ₹3,400 crores (37% YoY growth)
- Half-yearly revenue (H1 FY27): ₹6,490 crores (38% YoY growth)
EBITDA Performance:
- Quarterly EBITDA: ₹882 crores (30% YoY growth)
- Network EBITDA margin (including Sahyadri): 26%
- EBITDA margin (excluding Sahyadri): 27%
- Half-yearly EBITDA: ₹1,631 crores (28% YoY growth)
Volume Metrics:
- Inpatient volumes: 35% YoY growth
- Outpatient volumes: 27% YoY growth
- Average occupancy: 70% (vs 65% in Q1 FY27)
- Length of stay: 2.8 days (industry-leading)
- ARPOB (excluding Sahyadri): ₹77,000 per day (8% YoY growth)
- Network ARPOB: ₹70,600 per day
Profitability:
- PAT: ₹639 crores (H1 FY27)
- PAT margin: 10% (H1 FY27)
Operational Highlights (H1 FY27)
Digital Revenue:
- Digital contribution: 23% of overall revenue
- E-pharmacy: 34,000 orders across 26 hospitals in 4 metros
- Telehealth: 38,000 virtual consultations
- Chatbot/Manipal AI: 24,000 interactions
Specialty Performance:
- CONGO-R specialties (Cardiology, Oncology, Neurology, Gastroenterology, Orthopedics, Renal Sciences) contributed 64.2% of revenue
- Oncology, neurology, and orthopedics led growth with 43% increase
- Oncology revenue represents 12% of network revenue
Clinical Achievements:
- Installed world's latest Da Vinci 5 robotic surgical system at Delhi Dwarka hospital
- Introduced two-wheeler fleet first responder service in Bangalore
- Patiala hospital introduced advanced robotic-assisted orthopedic surgery
- Dhakuria Hospital performed first laser-guided renal artery angioplasty in Eastern India
- Electronic City hospital performed South India's first 5-ALA fluorescence-guided brain tumor surgery
- Goa Hospital performed state's first covered self-expandable metallic stent procedure
Sahyadri Hospitals Performance
Q2 FY27 Performance:
- Revenue: ₹375 crores (13% QoQ growth)
- EBITDA: ₹73 crores (26% QoQ growth)
- EBITDA margin: 19.5% (200 bps improvement from Q1 FY27)
- Digital revenue contribution: 11%
H1 FY27 Performance:
- Revenue: ₹707 crores (18% YoY growth)
- EBITDA: ₹131 crores (24% YoY growth)
Margin Progression:
- FY26: 15.5%
- Q1 FY27: 17.5%
- Q2 FY27: 19.5%
New Facility Performance
Bangalore Greenfield Hospitals:
- Kanakapura Hospital: 25% EBITDA margin (operating for 1+ year)
- Yelahanka Hospital: 24% EBITDA margin (operating for <1 year)
- Electronic City Hospital: EBITDA loss of ₹13 crores in Q2 (commissioned July/August 2026)
Expansion and Development Updates
Gurugram Project:
- Secured 3.5-acre land on long-term lease
- Phase 1: 500-bed multi-specialty tertiary care hospital
- Construction completion expected in 3-4 years
Kinder Hospital Acquisition:
- Completed acquisition of entire business operations and assets of Kinder Hospital, Bangalore
- To be repositioned as neighborhood multi-specialty hospital in Whitefield area
Bed Addition Plans:
- H2 FY27: 440-500 beds (greenfield and brownfield)
- FY28: 100 beds (brownfield) + 100 beds from Kinder Hospital repositioning
- Major additions expected from FY29 onwards including Mumbai facility
Regional Performance Insights
East India Cluster:
- Volume impact due to transition from Swasthya Sathi to Ayushman Bharat scheme
- Government business volumes de-grew by 17% in H1, but overall volumes positive due to cash/TPA growth
- New oncology team joined Dhakuria Hospital, Kolkata
- Annex building commissioned at Dhakuria Hospital (refurbished fire-affected AMRI building)
Karnataka Cluster:
- Added approximately 150 beds each in Kanakapura and Yelahanka
- Current occupancy around 100 beds in each new facility
Operational Strategy
Payer Mix:
- Government business: 13-14% of revenue
- Cash and TPA: ~80% of revenue (focus segment)
- Strategy focused on attracting cash and TPA patients through clinical team additions and digital initiatives
Capacity Utilization:
- Current occupancy: 70.7% in Q2 (from 65% in Q1)
- Target occupancy: ~80% at aggregate level
- No additional capex required to reach 80% occupancy
- Modular approach to bed commissioning based on volume growth
Integration and Synergies
Sahyadri Integration:
- Procurement synergies achieved
- Digital revenue increased from 1% to 11%
- 300 doctor profiles created online
- Senior liver transplant team (42 clinicians) joined November 1, 2026
- Insurance contract renegotiations ongoing under Sahyadri entity name
- Rebranding to Manipal Hospitals and legal entity change in progress
Guidance and Outlook
Sahyadri Margin Target:
- Expected to reach 23-24% EBITDA margin over 4-5 year period from acquisition
- Current trajectory: 15.5% (FY26) → 17.5% (Q1) → 19.5% (Q2)
Market Expansion Strategy:
- Continued focus on Tier 2/Tier 3 markets (Mysore, Mangalore, Patiala, Siliguri, Raipur)
- Raipur greenfield (350 beds Phase 1) expected in Q4 FY27
- Different approach for new markets (Mumbai, Raipur) vs densified markets (Bangalore)
- Mumbai Juhu facility: 602 beds, will follow phased commissioning approach
Financial Management
Finance Costs:
- Increased sequentially despite debt reduction due to debt repayment occurring on September 15, 2026
- Full benefit of interest cost reduction expected from Q3 FY27
Corporate Strategy
Business Focus:
- Core strength in tertiary and quaternary care
- No plans to expand into diagnostics or pharmaceutical retail
- Focus on out-of-hospital care including home care and digital health services
- Geographic expansion beyond Karnataka (eastern India leadership, western India presence, Delhi/NCR expansion)